Deborah Dunsire, an experienced pharmaceutical company chief executive, is set to become CEO of H. Lundbeck A/S on 1 September. Trained as a medical doctor, Dr Dunsire has managed both biotech and pharmaceutical companies in the fields of oncology and central nervous system disorders. Her most recent position is as CEO of the oncology company XTuit Pharmaceuticals Inc. She has also been CEO of FORUM Pharmaceuticals Inc and of Millennium Pharmaceuticals Inc, now part of Takeda Pharmaceutical Co Ltd.
